Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo.

Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo.

Item
http://www.wikidata.org/entity/Q34326588
Anticancer properties of distinct antimalarial drug classesDihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cellsCellular and molecular mechanisms underlie the anti-tumor activities exerted by Walterinnesia aegyptia venom combined with silica nanoparticles against multiple myeloma cancer cell types.Synergistic induction of apoptosis in A549 cells by dihydroartemisinin and gemcitabine.Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells.Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinomaEpigenetic targets in hepatocellular carcinoma cells: identification of chaperone protein complexes with histone deacetylases.Dihydroartemisinin inhibits the viability of cervical cancer cells by upregulating caveolin 1 and mitochondrial carrier homolog 2: Involvement of p53 activation and NAD(P)H:quinone oxidoreductase 1 downregulation.HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer.Antitumor Research on Artemisinin and Its Bioactive Derivatives.Effect of dihydroarteminin combined with siRNA targeting Notch1 on Notch1/c-Myc signaling in T-cell lymphoma cells.
P2860

Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo.

Item
http://www.wikidata.org/entity/Q34326588
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@ast
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@en
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@nl
type
label
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@ast
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@en
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@nl
prefLabel
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@ast
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@en
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Histone deacetylase inhibitors ...... r cancer in vitro and in vivo.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0039870
P407
P433
P478
P577
P5875
P698
P932